CN102793674B - Triptolide solid lipid nanoparticle as well as preparation method and application thereof - Google Patents
Triptolide solid lipid nanoparticle as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN102793674B CN102793674B CN201110139086.2A CN201110139086A CN102793674B CN 102793674 B CN102793674 B CN 102793674B CN 201110139086 A CN201110139086 A CN 201110139086A CN 102793674 B CN102793674 B CN 102793674B
- Authority
- CN
- China
- Prior art keywords
- water
- emulsion
- preparation
- triptolide
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002047 solid lipid nanoparticle Substances 0.000 title claims abstract description 127
- DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical compound O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 title claims abstract description 116
- YKUJZZHGTWVWHA-UHFFFAOYSA-N triptolide Natural products COC12CC3OC3(C(C)C)C(O)C14OC4CC5C6=C(CCC25C)C(=O)OC6 YKUJZZHGTWVWHA-UHFFFAOYSA-N 0.000 title claims abstract description 116
- 238000002360 preparation method Methods 0.000 title claims description 133
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 198
- 239000000839 emulsion Substances 0.000 claims abstract description 149
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 84
- 239000006185 dispersion Substances 0.000 claims abstract description 81
- 150000002632 lipids Chemical class 0.000 claims abstract description 75
- 239000003960 organic solvent Substances 0.000 claims abstract description 49
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 42
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 25
- 239000008367 deionised water Substances 0.000 claims abstract description 23
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 23
- 238000005507 spraying Methods 0.000 claims abstract description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 92
- 239000003921 oil Substances 0.000 claims description 64
- 235000019198 oils Nutrition 0.000 claims description 64
- 229960002668 sodium chloride Drugs 0.000 claims description 46
- 235000002639 sodium chloride Nutrition 0.000 claims description 46
- 239000011780 sodium chloride Substances 0.000 claims description 46
- 239000007788 liquid Substances 0.000 claims description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 39
- 230000001804 emulsifying effect Effects 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 25
- 239000008187 granular material Substances 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- -1 polyoxyethylene Polymers 0.000 claims description 19
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 18
- 102000002322 Egg Proteins Human genes 0.000 claims description 18
- 108010000912 Egg Proteins Proteins 0.000 claims description 18
- 241000287828 Gallus gallus Species 0.000 claims description 18
- 239000000787 lecithin Substances 0.000 claims description 18
- 235000010445 lecithin Nutrition 0.000 claims description 18
- 229940067606 lecithin Drugs 0.000 claims description 18
- 210000004681 ovum Anatomy 0.000 claims description 18
- 230000002085 persistent effect Effects 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 12
- 239000003223 protective agent Substances 0.000 claims description 11
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 10
- 238000009834 vaporization Methods 0.000 claims description 10
- 230000008016 vaporization Effects 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 8
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000005639 Lauric acid Substances 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 238000013019 agitation Methods 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 5
- 239000008117 stearic acid Substances 0.000 claims description 5
- 235000021357 Behenic acid Nutrition 0.000 claims description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 4
- 229940116226 behenic acid Drugs 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 4
- 229920000151 polyglycol Polymers 0.000 claims description 4
- 239000010695 polyglycol Substances 0.000 claims description 4
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 229940090181 propyl acetate Drugs 0.000 claims description 3
- OABYVIYXWMZFFJ-ZUHYDKSRSA-M sodium glycocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 OABYVIYXWMZFFJ-ZUHYDKSRSA-M 0.000 claims description 3
- 229940083466 soybean lecithin Drugs 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 229920001993 poloxamer 188 Polymers 0.000 claims description 2
- 229940044519 poloxamer 188 Drugs 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims 2
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 claims 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 32
- 238000000034 method Methods 0.000 abstract description 12
- 238000004945 emulsification Methods 0.000 abstract description 6
- 239000012528 membrane Substances 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 4
- 239000002105 nanoparticle Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 2
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 238000010008 shearing Methods 0.000 abstract 1
- 239000005288 shirasu porous glass Substances 0.000 description 41
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 22
- 239000003814 drug Substances 0.000 description 15
- 229960001947 tripalmitin Drugs 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 6
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 5
- 229940049654 glyceryl behenate Drugs 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 241000545405 Tripterygium Species 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a method for preparing triptolide solid lipid nanoparticles by quick membrane emulsification. The method comprises the following steps of: dissolving triptolide and mixed lipid into an organic solvent to serve as an oil phase, and dispersing into deionized water with an emulsifying agent; performing high-speed shearing emulsification at temperature higher than a melting point of the mixed lipid to obtain O/W type pre-emulsion; circulating the pre-emulsion under nitrogen pressure by adopting quick membrane emulsification equipment, and obtaining O/W type emulsion; and removing the organic solvent, and solidifying the lipid particles to obtain a solid lipid nanoparticle dispersion solution, or centrifugally separating the dispersion solution to collect the nanoparticles, or performing spraying drying or freezing drying to obtain the triptolide solid lipid nanoparticles. The triptolide solid lipid nanoparticles are high in monodispersity, high in entrapment efficiency and stable in process.
Description
Technical field
The invention belongs to the preparation method of nanoparticle raw materials medicine, be specifically related to a kind of triptolide solid lipid nano-particles and its preparation method and application.
Background technology
Triptolide (Triptolide, TP), claim again Radix Tripterygii Wilfordii lactone alcohol, from Celastraceae Thunder God Calamus Radix Tripterygii Wilfordii (Tripterygium Wilfordii Hook.f, TWHf) a kind of diterpenic lactone that in, separation obtains, be one of main effective ingredient in Radix Tripterygii Wilfordii, molecular formula is C
20h
24o
6, molecular weight is 360.4, is insoluble in water, is dissolved in the organic solvents such as methanol, ethanol, propylene glycol, acetone, dimethyl sulfoxide, ultraviolet maximum absorption wavelength is 218nm.Its chemical structural formula as shown in Figure 1.
Triptolide has significant immunosuppressive action, can be used for treating the dermatosis such as rheumatoid arthritis, chronic nephritis and lupus erythematosus, psoriasis, has very strong resisting transplant rejection effect simultaneously.Yet triptolide toxicity is large, the LD of the quiet note of mice and lumbar injection first element
50be respectively 0.8mg/kg, 0.9mg/kg.See children Zheng orchid etc., " Triptolide some toxicity to mice and dog ", Acta Pharmacologica Sinica, 1981,2 (1): 70-72.Conventional formulation intravenous injection easily causes that vein festers, and oral have strong impulse effect to gastrointestinal tract.
The triptolide half-life is in vivo short, easily by metabolism.Oral Administration in Rats first element dosage 0.6,1.2 and 2.4mg/kg, peak reaching time of blood concentration is in 15min, and the elimination half-life is 16.81～21.70min.Intravenous injection first element, dosage 0.6mg/kg, after 48h, the medication amount in excrement, bile, urine is respectively 0.03%, 0.43% and 0.06% of dosage, shows that first element is drained with the form of metabolite.See Shao F, Wang GJ, Xie HT, et al. < < Pharmacokinetic study of triptolide, aconstituent of immunosuppressive Chinese herb medicine, in Rats > > .Biol.Pharm.Bull., 2007,30 (4): 702-707.
Solid lipid nano-particles (solid lipid nanoparticle, SLN) is the administration nano-drug administration system of new generation growing up the nineties in 20th century, is the colloidal particle forming by being at room temperature solid-state biodegradable lipid.SLN can improve the oral administration biaavailability of insoluble drug, thereby reduces using dosage, and this administration for toxic medicament triptolide is very significant.
Existing solid lipid nano-particles preparation method mainly contains high pressure homogenize, high speed shear and supersound process etc.These method energy expenditures are high, violent high pressure, at a high speed, the mechanism such as high shear may cause medicine degeneration and loss, causes envelop rate to reduce.
SLN can delay Slow release, the prolong drug half-life.The means that realize at present SLN slow release are mainly to select suitable lipid carrier and technique to make the kernel of more medicine in granule, or the release that delays medicine of covalent bond or electrostatic interaction by medicine and lipid carrier, and particle diameter and particle size distribution are paid close attention to less on the impact discharging.
Existing SLN preparation technology cannot accurately control particle diameter and particle size distribution, and stable preparation process is poor.And film emulsifying (Membrane emulsification) technology can, by the selection of film parameter and film emulsion process parameter, realize the accuracy controlling to the particle diameters such as Emulsion or microsphere/microcapsule and particle size distribution.Film emulsifying technology is the new method of preparing Emulsion (single breast, how newborn) and microsphere/microcapsule growing up on membrane technology basis.Its stable preparation process is good, and entrapment efficiency is high, and preparation condition is gentle, and energy expenditure is low, is easy to industry and amplifies, and in fields such as biological medicine, food, chemical industry, has represented good application prospect.A kind of fast film emulsifying technology that grows up again in recent years, claims again pre-emulsion film emulsifying (Premix membrane), first prepares pre-emulsion, then by pre-emulsion under elevated pressures by the fenestra of uniform particle diameter, obtain the emulsion of homogeneous.Because the preparation efficiency of the method emulsion is high, can prepare the emulsion droplet that particle diameter is less, therefore than direct film emulsifying technology, there is the scope of application widely.
Summary of the invention
The invention provides a kind of preparation method of triptolide solid lipid nano-particles, solving existing solid lipid nano-particles preparation method cannot accurately control particle diameter and distribution thereof, and the problem of poor reproducibility, for Tripterygium Preparations provides, monodispersity is good, envelop rate is high, the crude drug of process stabilizing.
The preparation method of a kind of triptolide solid lipid nano-particles of the present invention, comprises the following steps:
(1) pre-emulsion preparation: triptolide is dissolved in organic solvent as oil phase with mixing lipid, and the mass ratio of triptolide and mixing lipid is 1: 10～1: 1000, and the mass volume ratio of mixing lipid and organic solvent is 1g: 5～10mL;
Oil phase is scattered in water, oil phase and water volume ratio are 1: 2～1: 20 again, adopt high-shear emulsifying to obtain oil-in-water type pre-emulsion;
Water is the deionized water that contains emulsifying agent, and the mass ratio of emulsifying agent and deionized water is 1: 10～1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, by the circulation of oil-in-water type pre-emulsion, prepare emulsion oil-in-water;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation 24h or reduction vaporization 1～2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions; Or sodium-chloride water solution is added to described emulsion oil-in-water, organic solvent is diffused in sodium-chloride water solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 2～6: 1, and the mass percentage concentration of sodium-chloride water solution is 0.88-0.92%;
(4) solid nano granule preparation: by solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid or carry out centrifugalize, or spraying is dry or lyophilization, obtains triptolide solid lipid nano-particles.
Described preparation method, preferably, in described pre-emulsion preparation process, mix lipid and mix and form by lipoid and lipid carrier, the mass ratio of lipoid and lipid carrier is 1: 2～1: 5, and described lipoid is a kind of in soybean lecithin, Ovum Gallus domesticus Flavus lecithin, phosphatidylcholine; Described lipid carrier is a kind of in satisfied fatty acid, saturated fatty acid glyceride, liquid oil or the mixture of two kinds wherein;
Described satisfied fatty acid is a kind of in stearic acid, Palmic acid, myristic acid, lauric acid, capric acid, behenic acid or the mixture of two kinds wherein;
Described saturated fatty acid glyceride class is the triglyceride of stearic acid, Palmic acid, myristic acid, lauric acid, capric acid, behenic acid, double glyceride, monoglyceride or two or three mixture wherein;
Described liquid oil be sad three sweet/a kind of in capric acid triglyceride, isopropyl myristate, isopropyl palmitate, the own fat of lauric acid, oleic acid, linoleic acid, Masine 35-1, soybean oil or the mixture of two kinds wherein.
Described preparation method, in described pre-emulsion preparation process, organic solvent is preferably a kind of in dichloromethane, chloroform, ethyl acetate, propyl acetate, toluene, ethanol, isopropyl alcohol, acetone, benzyl alcohol, butyl lactate or the mixture of two kinds wherein.
Described preparation method, in described pre-emulsion preparation process, described emulsifying agent is preferably polyvinyl alcohol, tween 80, tween 20, Tween-40, Arlacel-80, Arlacel-20, Myrij (Myrij) 52, Myrij (Myrij) 53, Brij (Brij) 30, Brij (Brij) 35, PLURONICS F87, poloxamer188, polyoxyethylene castor oil, polyoxyethylene hydrogenated Oleum Ricini, polyglycol distearate, dodecyl sodium sulfate (SDS), sodium cholate, NaTDC, sodium glycocholate, deoxidation natrii tauroglycocholas, glycerol, butanols, isoamyl alcohol, 1, a kind of in 2-propylene glycol or the wherein mixture of two kinds.
In described pre-emulsion preparation process, take high-shear emulsifying to obtain oil-in-water type pre-emulsion, rotating speed is 10,000r/min～30,000r/min, persistent period 1min～5min.
In described solid nano granule preparation process, when solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid are carried out to centrifugalize, centrifugal speed is 1,000r/min～5,000r/min, persistent period 10min～30min.
Described preparation method, in described solid nano granule preparation process, when solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid are sprayed to dry or lyophilization, spraying is dried or cryodesiccated protective agent is selected from polyvinylpyrrolidone, hydroxypropyl emthylcellulose, maltose, lactose, mannitol, glucose, trehalose, arabic gum, xylitol, sorbitol, fructose, a kind of in sucrose, the mass volume ratio of protective agent and solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid is 1g: 5～100mL.
Another object of the present invention is to provide a kind of triptolide solid lipid nano-particles and application thereof.
Concrete technical scheme is as follows:
The triptolide solid lipid nano-particles that method prepares from the above mentioned.
The application of described triptolide solid lipid nano-particles in preparing triptolide injection, oral or preparation capable of permeating skin.
Research shows, the monodispersed drug-loading system of particle diameter has good control for dosage and the release behavior of packaging medicine, has higher envelop rate.The size of drug-loading system and particle size distribution are one of key factors of the desirable Nano medication consideration of exploitation, and for maintaining, steadily effectively blood drug level is extremely important.
The present invention adopts pre-emulsification in conjunction with SPG film emulsifying technology, take and mixes lipid as carrier material, parcel triptolide.The characteristic of the advantage of binding film technology of the present invention and solid lipid nano-particles itself, preparation method is simple and quick, mild condition, process stabilizing, triptolide solid lipid nano-particles particle diameter is less than 500nm, polydispersity coefficient (PDI) 0.02～0.2, envelop rate 60%～90%.Described triptolide solid lipid nano-particles can be used for preparing triptolide injection, oral or preparation capable of permeating skin.
Accompanying drawing explanation
Fig. 1 is the chemical structural formula of triptolide.
Fig. 2 is triptolide solid lipid nano-particles particle diameter and scattergram thereof in embodiment 3.
Fig. 3 is triptolide solid lipid nano-particles particle diameter and scattergram thereof in embodiment 5.
Fig. 4 is triptolide solid lipid nano-particles particle diameter and scattergram thereof in embodiment 7.
Fig. 5 is triptolide solid lipid nano-particles particle diameter and scattergram thereof in embodiment 8.
The specific embodiment
The fast film emulsifying device adopting in the method for the invention, for Japan (SPG Technology Co., Ltd) company produces; Inorganic microporous glass (SPG, Shirasu porous glass) film is tubular film, external diameter 10mm, thickness 0.4mm～1mm, length 20mm, aperture 0.1 μ m～1 μ m.Under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 1～7 time, obtain emulsion oil-in-water, nitrogen pressure is 70～140psi (Pounds per square inch).
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 3.2g, Masine 35-1 0.8g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 6.0g, is heated to 60 ℃, 30,000r/min, high shear 1min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 1 time, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 1 μ m, nitrogen pressure is 70psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 1,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 345.4nm, polydispersity coefficient (PDI) 0.081, envelop rate 70%.
Embodiment 2
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 3.2g, Masine 35-1 0.8g, be dissolved in 30mL ethyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 6.0g, is heated to 60 ℃, 30,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 2 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 1 μ m, nitrogen pressure is 70psi;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation 24h and remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the lyophilization of solid lipid nano-particles aqueous dispersions, take trehalose as protective agent, consumption 0.6g, the amount ratio of 1g trehalose and solid lipid nano-particles aqueous dispersions is 100mL.
This triptolide solid lipid nano-particles particle diameter 332.4nm, polydispersity coefficient (PDI) 0.054, envelop rate 68%.
Embodiment 3
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 3.2g, Masine 35-1 0.8g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 6.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 90psi;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation 24h and remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 5,000r/min, and persistent period 10min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 304.7nm, polydispersity coefficient (PDI) 0.023, envelop rate 74%, particle diameter and distribution thereof are as Fig. 2.
Embodiment 4
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 6.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 90psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 1h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 315.3nm, polydispersity coefficient (PDI) 0.068, envelop rate 85%.
Embodiment 5
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation process: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 5.0g and sodium cholate 1.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 4 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 100psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 1h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the lyophilization of solid lipid nano-particles aqueous dispersions, take trehalose as protective agent, consumption 12.0g, with solid lipid nano-particles aqueous dispersions amount ratio be 1g: 5mL.
This triptolide solid lipid nano-particles particle diameter 180.9nm, polydispersity coefficient (PDI) 0.097, envelop rate 83%, particle diameter and distribution thereof are as Fig. 3.
Embodiment 6
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the consumption that mixes lipid summation and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 5.0g and sodium cholate 1.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 4 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 100psi;
(3) dispersion liquid preparation: be that 0.9% sodium-chloride water solution 540mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium chloride solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 6: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 190.5nm, polydispersity coefficient (PDI) 0.069, envelop rate 82%.
Embodiment 7
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 5.0g and sodium cholate 1.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 4 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.1 μ m, nitrogen pressure is 130psi;
(3) dispersion liquid preparation: be that 0.9% sodium-chloride water solution 540mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium-chloride water solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 6: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 85.03nm, polydispersity coefficient (PDI) 0.100, envelop rate 75%, particle diameter and distribution thereof are as Fig. 4.
Embodiment 8
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 6.0mg, Ovum Gallus domesticus Flavus lecithin 1.0g, Glyceryl Behenate 3.0g, caprylic/capric triglyceride 2.0g, be dissolved in the mixed solvent of 60mL dichloromethane and ethyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 5, the mass ratio of triptolide and mixing lipid is 1: 1000, and the amount ratio that mixes lipid and organic solvent is 1g: 10mL;
Again oil phase is scattered in 1200mL water, in water, containing polyvinyl alcohol 12.0g, is heated to 80 ℃, 30,000r/min, high shear 1min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 20, and the mass ratio of emulsifying agent and deionized water is 1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 2 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 100psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation process: solid lipid nano-particles aqueous dispersions spraying is dry, take hydroxypropyl emthylcellulose as protective agent, consumption 12.0g, with solid lipid nano-particles aqueous dispersions amount ratio be 1g: 100mL.
This triptolide solid lipid nano-particles particle diameter 423.2nm, polydispersity coefficient (PDI) 0.022, envelop rate 85%, particle diameter and distribution thereof are as Fig. 5.
Embodiment 9
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 6.0mg, Ovum Gallus domesticus Flavus lecithin 1.0g, Glyceryl Behenate 2.0g, Masine 35-1 3.0g, be dissolved in the mixed solvent of 60mL dichloromethane and ethyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 5, the mass ratio of triptolide and mixing lipid is 1: 1000, and the amount ratio that mixes lipid and organic solvent is 1g: 10mL;
Again oil phase is scattered in 1200mL water, in water, containing polyvinyl alcohol 10.0g and sodium cholate 2.0g, is heated to 80 ℃, 30,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 20, and the mass ratio of emulsifying agent and deionized water is 1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 120psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: the spraying of solid lipid nano-particles aqueous dispersions is dry, take hydroxypropyl emthylcellulose as protective agent, consumption 12.0g, with solid lipid nano-particles aqueous dispersions amount ratio be 1g: 100mL.
This triptolide solid lipid nano-particles particle diameter 310.6nm, polydispersity coefficient (PDI) 0.025, envelop rate 90%.
Embodiment 10
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 6.0mg, Ovum Gallus domesticus Flavus lecithin 1.0g, Glyceryl Behenate 2.0g, Masine 35-1 3.0g, be dissolved in the mixed solvent of 60mL dichloromethane and ethyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 5, the mass ratio of triptolide and mixing lipid is 1: 1000, and the amount ratio that mixes lipid and organic solvent is 1g: 10mL;
Again oil phase is scattered in 1200mL water, in water, containing polyvinyl alcohol 10.0g and sodium cholate 2.0g, is heated to 80 ℃, 30,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 20, and the mass ratio of emulsifying agent and deionized water is 1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.5 μ m, nitrogen pressure is 140psi;
(3) dispersion liquid preparation: be that 0.9% sodium-chloride water solution 2520mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium chloride solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 2: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 10min obtains triptolide solid lipid nano-particles.
This triptolide solid lipid nano-particles particle diameter 180.2nm, polydispersity coefficient (PDI) 0.103, envelop rate 88%.
Embodiment 11
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, soybean lecithin 2.0g, stearic acid 3.2g, isopropyl myristate 0.8g, be dissolved in 30mL isopropyl alcohol as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyglycol distearate 6.0g, is heated to 70 ℃, 30,000r/min, high shear 1min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 1 time, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 1 μ m, nitrogen pressure is 70psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 1,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
Embodiment 12
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, phosphatidylcholine 2.0g, tripalmitin 3.2g, oleic acid 0.8g, be dissolved in 30mL propyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene castor oil 6.0g, is heated to 60 ℃, 30,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 2 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 1 μ m, nitrogen pressure is 70psi;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation 24h and remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the lyophilization of solid lipid nano-particles aqueous dispersions, take mannitol as protective agent, consumption 0.6g, the amount ratio of 1g trehalose and solid lipid nano-particles aqueous dispersions is 100mL.
Embodiment 13
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tristerin 3.2g, isopropyl palmitate 0.8g, be dissolved in 30mL chloroform as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing tween 20 6.0g, is heated to 70 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 90psi;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation 24h and remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 5,000r/min, and persistent period 10min obtains triptolide solid lipid nano-particles.
Embodiment 14
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, being dissolved in 30mL butyl lactate is oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing PLURONICS F87 6.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 0.4mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 90psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 1h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles aqueous dispersions, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
Embodiment 15
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL benzyl alcohol as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the consumption that mixes lipid summation and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyglycol distearate 5.0g and deoxidation natrii tauroglycocholas 1.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 4 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 100psi;
(3) dispersion liquid preparation: be that 0.88% sodium-chloride water solution 540mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium chloride solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 6: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
Embodiment 16
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 600mg, Ovum Gallus domesticus Flavus lecithin 2.0g, tripalmitin 2.0g, Masine 35-1 2.0g, be dissolved in 30mL dichloromethane as oil phase, the mass ratio of lipoid and lipid carrier is 1: 2, the mass ratio of triptolide and mixing lipid is 1: 10, and the amount ratio that mixes lipid and organic solvent is 1g: 5mL;
Again oil phase is scattered in 60mL water, in water, containing polyoxyethylene hydrogenated Oleum Ricini 5.0g and sodium glycocholate 1.0g, is heated to 60 ℃, 10,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 2, and the mass ratio of emulsifying agent and deionized water is 1: 10;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 4 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.1 μ m, nitrogen pressure is 130psi;
(3) dispersion liquid preparation: be that 0.92% sodium-chloride water solution 540mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium chloride solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium chloride solution and emulsion oil-in-water is 6: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 30min obtains triptolide solid lipid nano-particles.
Embodiment 17
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 6.0mg, Ovum Gallus domesticus Flavus lecithin 1.0g, Glyceryl Behenate 3.0g, linoleic acid 2.0g, be dissolved in the mixed solvent of 60mL chloroform and acetone as oil phase, the mass ratio of lipoid and lipid carrier is 1: 5, the mass ratio of triptolide and mixing lipid is 1: 1000, and the amount ratio that mixes lipid and organic solvent is 1g: 10mL;
Again oil phase is scattered in 1200mL water, in water, containing polyvinyl alcohol 12.0g, is heated to 80 ℃, 30,000r/min, high shear 1min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 20, and the mass ratio of emulsifying agent and deionized water is 1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 2 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.7 μ m, nitrogen pressure is 100psi;
(3) dispersion liquid preparation: to described emulsion oil-in-water reduction vaporization 2h, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions;
(4) solid nano granule preparation process: solid lipid nano-particles aqueous dispersions spraying is dry, take glucose as protective agent, consumption 12.0g, with solid lipid nano-particles aqueous dispersions amount ratio be 1g: 100mL.
Embodiment 18
The preparation method of triptolide solid lipid nano-particles described in the present embodiment, comprises the following steps:
(1) pre-emulsion preparation: by triptolide 6.0mg, Ovum Gallus domesticus Flavus lecithin 1.0g, Glyceryl Behenate 2.0g, Masine 35-1 3.0g, be dissolved in the mixed solvent of 60mL dichloromethane and ethyl acetate as oil phase, the mass ratio of lipoid and lipid carrier is 1: 5, the mass ratio of triptolide and mixing lipid is 1: 1000, and the amount ratio that mixes lipid and organic solvent is 1g: 10mL;
Again oil phase is scattered in 1200mL water, in water, containing polyvinyl alcohol 10.0g and dodecyl sodium sulfate 2.0g, is heated to 80 ℃, 30,000r/min, high shear 5min obtains oil-in-water type pre-emulsion; Oil phase and water volume ratio are 1: 20, and the mass ratio of emulsifying agent and deionized water is 1: 100;
(2) emulsion preparation: utilize fast film emulsifying device, under nitrogen pressure, make oil-in-water type pre-emulsion cycle through SPG film 3 times, obtain emulsion oil-in-water, SPG film thickness 1mm, length 20mm, aperture 0.5 μ m, nitrogen pressure is 140psi;
(3) dispersion liquid preparation: be that 0.92% sodium-chloride water solution 2520mL adds described emulsion oil-in-water by mass percentage concentration, organic solvent is diffused in sodium chloride solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 2: 1;
(4) solid nano granule preparation: by the centrifugalize of solid lipid nano-particles sodium chloride dispersion liquid, centrifugal speed is 5,000r/min, and persistent period 10min obtains triptolide solid lipid nano-particles.
Be more than for the illustrating of possible embodiments of the present invention, but this embodiment is not in order to limit the scope of the claims of the present invention, allly do not depart from the equivalence that skill spirit of the present invention does and implement or change, all should be contained in the scope of the claims of the present invention.
Claims (8)
1. a preparation method for triptolide solid lipid nano-particles, is characterized in that, comprises the following steps:
(1) pre-emulsion preparation: triptolide is dissolved in organic solvent as oil phase with mixing lipid, and the mass ratio of triptolide and mixing lipid is 1:10～1000, and the amount ratio of mixing lipid and organic solvent is 1g:5～10mL;
Oil phase is scattered in water, oil phase and water volume ratio are 1:2～1:20 again, adopt high-shear emulsifying to obtain oil-in-water type pre-emulsion;
Described water is the deionized water that contains emulsifying agent, and the mass ratio of emulsifying agent and deionized water is 1:10～1:100;
Described mixing lipid is mixed and is formed by lipoid and lipid carrier, and the mass ratio of described lipoid and lipid carrier is 1:2～1:5, and described lipoid is a kind of in soybean lecithin, Ovum Gallus domesticus Flavus lecithin, phosphatidylcholine; Described lipid carrier is a kind of in satisfied fatty acid, saturated fatty acid glyceride, liquid oil or the mixture of two kinds wherein;
Described satisfied fatty acid is a kind of in stearic acid, Palmic acid, myristic acid, lauric acid, capric acid, behenic acid or the mixture of two kinds wherein;
Described saturated fatty acid glyceride is the triglyceride, double glyceride, monoglyceride of stearic acid, Palmic acid, myristic acid, lauric acid, capric acid, behenic acid or two or three mixture wherein;
Described liquid oil is a kind of in caprylic/capric triglyceride, isopropyl myristate, isopropyl palmitate, the own fat of lauric acid, oleic acid, linoleic acid, Masine 35-1, soybean oil or the mixture of two kinds wherein;
(2) emulsion preparation: utilize fast film emulsifying device, make oil-in-water type pre-emulsion cycle through SPG film 1～7 time under nitrogen pressure, obtain emulsion oil-in-water, described nitrogen pressure is 70～140psi;
(3) dispersion liquid preparation: described emulsion oil-in-water is carried out to magnetic agitation or reduction vaporization, remove organic solvent, obtain solid lipid nano-particles aqueous dispersions; Or sodium-chloride water solution is added to described emulsion oil-in-water, organic solvent is diffused in sodium-chloride water solution, obtain solid lipid nano-particles sodium chloride dispersion liquid, the volume ratio of sodium-chloride water solution and emulsion oil-in-water is 2～6:1, and the mass percentage concentration of sodium-chloride water solution is 0.88-0.92%;
(4) solid nano granule preparation: by solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid or carry out centrifugalize, or spraying is dry or lyophilization, obtains triptolide solid lipid nano-particles.
2. preparation method as claimed in claim 1, is characterized in that, described organic solvent is a kind of in dichloromethane, chloroform, ethyl acetate, propyl acetate, toluene, ethanol, isopropyl alcohol, acetone, benzyl alcohol, butyl lactate or the mixture of two kinds wherein.
3. preparation method as claimed in claim 1, it is characterized in that, described emulsifying agent is a kind of in polyvinyl alcohol, tween 80, tween 20, Tween-40, Arlacel-80, Arlacel-20, Myrj 52, Myrj 53, Brij30, Brij35, PLURONICS F87, poloxamer188, polyoxyethylene castor oil, polyoxyethylene hydrogenated Oleum Ricini, polyglycol distearate, dodecyl sodium sulfate, sodium cholate, NaTDC, sodium glycocholate, deoxidation natrii tauroglycocholas, glycerol, butanols, isoamyl alcohol, 1,2-PD or the mixture of two kinds wherein.
4. the preparation method as described in claim 1-3 any one, is characterized in that, adopts high-shear emulsifying to obtain oil-in-water type pre-emulsion in step (1), and rotating speed is 10,000r/min～30,000r/min, persistent period 1min～5min.
5. the preparation method as described in claim 1-3 any one, it is characterized in that, while solid lipid nano-particles aqueous dispersions or solid lipid nano-particles sodium chloride dispersion liquid being carried out to centrifugalize in step (4), centrifugal speed is 1,000r/min～5,000r/min, persistent period 10min～30min.
6. the preparation method as described in claim 1-3 any one; it is characterized in that; in step (4) middle spray dry or lyophilization, adopt protective agent; described protective agent is selected from a kind of in polyvinylpyrrolidone, hydroxypropyl emthylcellulose, maltose, lactose, mannitol, glucose, trehalose, arabic gum, xylitol, sorbitol, fructose, sucrose, and the amount ratio of protective agent and solid lipid nano-particles dispersion liquid is 1g:5～100mL.
7. the triptolide solid lipid nano-particles being prepared by the preparation method described in claim 1-6 any one.
8. the application of triptolide solid lipid nano-particles claimed in claim 7 in preparing triptolide injection, oral or preparation capable of permeating skin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110139086.2A CN102793674B (en) | 2011-05-26 | 2011-05-26 | Triptolide solid lipid nanoparticle as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110139086.2A CN102793674B (en) | 2011-05-26 | 2011-05-26 | Triptolide solid lipid nanoparticle as well as preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102793674A CN102793674A (en) | 2012-11-28 |
| CN102793674B true CN102793674B (en) | 2014-11-26 |
Family
ID=47193146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110139086.2A Expired - Fee Related CN102793674B (en) | 2011-05-26 | 2011-05-26 | Triptolide solid lipid nanoparticle as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102793674B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160038454A1 (en) * | 2013-03-15 | 2016-02-11 | Pharmagenesis, Inc. | Intravenous formulations of triptolide compounds as immunomodulators and anticancer agents |
| ES2865375T3 (en) * | 2014-11-05 | 2021-10-15 | Selecta Biosciences Inc | Methods and compositions related to synthetic nanocarriers with rapamycin in a stable supersaturated state |
| US10342797B2 (en) | 2016-03-13 | 2019-07-09 | LivePet, LLC | Solubility of therapeutic agents |
| CN107050037A (en) * | 2017-05-16 | 2017-08-18 | 广东艾时代生物科技有限责任公司 | Application and its pharmaceutical composition of the triptolide in anti-malaria medicaments are prepared |
| CN108635338B (en) * | 2018-05-15 | 2020-07-31 | 复旦大学附属肿瘤医院 | Triptolide lipid nanoparticle for external use and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543932A (en) * | 2003-11-25 | 2004-11-10 | 华中科技大学 | Application of solid liposome nanoparticle for preparing pharmaceutical used for ion leading-in trandermal therapy |
-
2011
- 2011-05-26 CN CN201110139086.2A patent/CN102793674B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543932A (en) * | 2003-11-25 | 2004-11-10 | 华中科技大学 | Application of solid liposome nanoparticle for preparing pharmaceutical used for ion leading-in trandermal therapy |
Non-Patent Citations (6)
| Title |
|---|
| A.Nazir,et al.Premix emulsification: A review.《Journal of Membrane Science》.2010,第362卷第1-11页. * |
| Premix emulsification: A review;A.Nazir,et al;《Journal of Membrane Science》;20101231;第362卷;第1-11页 * |
| 膜乳化技术及其在微粒给药系统中的运用;顾立等;《第三届国际药物制剂论坛论文集》;20071001;第219-222页 * |
| 膜乳化技术在微粒给药系统中的应用;顾立等;《中国医药工业杂志》;20071231;第38卷(第11期);第814-818页 * |
| 顾立等.膜乳化技术及其在微粒给药系统中的运用.《第三届国际药物制剂论坛论文集》.2007,第219-222页. * |
| 顾立等.膜乳化技术在微粒给药系统中的应用.《中国医药工业杂志》.2007,第38卷(第11期),第814-818页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102793674A (en) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ganesan et al. | Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery | |
| CN102793674B (en) | Triptolide solid lipid nanoparticle as well as preparation method and application thereof | |
| Sun et al. | Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability | |
| CN100341485C (en) | Anticancer compositions | |
| Elbahwy et al. | Enhancing bioavailability and controlling the release of glibenclamide from optimized solid lipid nanoparticles | |
| Bansal et al. | Nanocrystals: current strategies and trends | |
| Garg et al. | In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles | |
| KR101003204B1 (en) | Solid lipid nanoparticles for drug delivery, a process for the preparatrion thereof, and an injection comprising the same | |
| Wang et al. | In vitro and in vivo evaluation of taxol release from poly (lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres | |
| CN102824356A (en) | Baicalin nano crystal suspension, nano crystal dry powder and methods for preparing baicalin nano crystal suspension and nano crystal dry powder | |
| Guo et al. | Novel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitine | |
| EP1893176A1 (en) | Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying | |
| CN103877021B (en) | Silybin nanostructured brilliant self-stabilization Pickering emulsion and preparation method thereof | |
| Xu et al. | Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly (ethylene glycol)-poly (D, L-lactide) nanoparticle with longer survival time | |
| AU2016228941B2 (en) | Drug delivery composition comprising polymer-lipid hybrid microparticles | |
| CN101703482A (en) | Galanthamine long-acting release injectable microsphere composite and preparation method thereof | |
| Sailor et al. | Design of experiment approach based formulation optimization of berberine loaded solid lipid nanoparticle for antihyperlipidemic activity | |
| CN104367549B (en) | Contain psoralen adriamycin composite nanostructure lipid vector preparation and preparation method thereof | |
| CN103690491A (en) | Preparation method of PEG-PLA/PLA composite drug loaded nanometer microballoon | |
| KR101005562B1 (en) | Preparation method of homogeneous sized polymer nanoparticles containing water-insoluble drugs | |
| Dey et al. | Development and in vitro evaluation of Letrozole loaded biodegradable nanoparticles for breast cancer therapy | |
| Zafar et al. | Bergenin nano-lipid carrier to improve the oral delivery: development, optimization, in vitro and in vivo evaluation | |
| CN103070825A (en) | Curcumin particle suspension used for intramuscular injection and hypodermic injection, preparation method and application | |
| CN103083240A (en) | Preparation of solid dispersions and oral preparations of paclitaxel and homologous compounds thereof | |
| CN102048702B (en) | Bifendate nano-crystalline preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 Termination date: 20180526 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |